Jan 18 (Reuters) - PHARMA MAR SA:
* CORAIL PHASE III WITH ZEPSYRE IN RESISTANT OVARIAN CANCER HAS NOT MET ITS PRIMARY ENDPOINT Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
 